Cargando…

Immune responses in multiple hosts to Nucleocapsid Protein (NP) of Crimean-Congo Hemorrhagic Fever Virus (CCHFV)

In 2019, the World Health Organization declared 3 billion to be at risk of developing Crimean Congo Hemorrhagic Fever (CCHF). The causative agent of this deadly infection is CCHFV. The data related to the biology and immunology of CCHFV are rather scarce. Due to its indispensable roles in the viral...

Descripción completa

Detalles Bibliográficos
Autores principales:	Karaaslan, Elif, Çetin, Nesibe Selma, Kalkan-Yazıcı, Merve, Hasanoğlu, Sevde, Karakeçili, Faruk, Özdarendeli, Aykut, Kalkan, Ahmet, Kılıç, Ali Osman, Doymaz, Mehmet Ziya
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8635347/ https://www.ncbi.nlm.nih.gov/pubmed/34851958 http://dx.doi.org/10.1371/journal.pntd.0009973

Ejemplares similares

Evaluation of the cell culture based and the mouse brain derived inactivated vaccines against Crimean-Congo hemorrhagic fever virus in transiently immune-suppressed (IS) mouse model
por: Pavel, Shaikh Terkis Islam, et al.
Publicado: (2020)

Crimean–Congo Hemorrhagic Fever Virus: Progress in Vaccine Development
por: Ozdarendeli, Aykut
Publicado: (2023)

Crimean-Congo Hemorrhagic Fever Virus (CCHFV): A Silent but Widespread Threat
por: Kuehnert, Paul A., et al.
Publicado: (2021)

Pseudo-plaque reduction neutralization test (PPRNT) for the measurement of neutralizing antibodies to Crimean-Congo hemorrhagic fever virus
por: Canakoglu, Nurettin, et al.
Publicado: (2013)

Evaluation of Portal Vein Doppler Findings in Patients with Crimean–Congo Hemorrhagic Fever
por: Karavaş, Erdal, et al.
Publicado: (2019)

Immunization of Knock-Out α/β Interferon Receptor Mice against High Lethal Dose of Crimean-Congo Hemorrhagic Fever Virus with a Cell Culture Based Vaccine
por: Canakoglu, Nurettin, et al.
Publicado: (2015)

Development of a protective inactivated vaccine against Crimean–Congo hemorrhagic fever infection
por: Berber, Engin, et al.
Publicado: (2021)

Fine Epitope Mapping of the Central Immunodominant Region of Nucleoprotein from Crimean-Congo Hemorrhagic Fever Virus (CCHFV)
por: Liu, Dongliang, et al.
Publicado: (2014)

Development of multivalent vaccine targeting M segment of Crimean Congo Hemorrhagic Fever Virus (CCHFV) using immunoinformatic approaches
por: Sana, Maaza, et al.
Publicado: (2022)

Transmission Dynamics of Crimean–Congo Haemorrhagic Fever Virus (CCHFV): Evidence of Circulation in Humans, Livestock, and Rodents in Diverse Ecologies in Kenya
por: Omoga, Dorcus C. A., et al.
Publicado: (2023)

Neutralization of Wild-Type and Alpha SARS-CoV-2 Variant by CoronaVac® Vaccine and Natural Infection- Induced Antibodies
por: Özkaya, Esra, et al.
Publicado: (2023)

The interplays between Crimean-Congo hemorrhagic fever virus (CCHFV) M segment-encoded accessory proteins and structural proteins promote virus assembly and infectivity
por: Freitas, Natalia, et al.
Publicado: (2020)

The Seroprevalence of Crimean-Congo Hemorrhagic Fever in Wild and Domestic Animals: An Epidemiological Update for Domestic Animals and First Seroevidence in Wild Animals from Turkiye
por: Nurettin, Canakoglu, et al.
Publicado: (2022)

Risk of Crimean Congo haemorrhagic fever virus (CCHFV) introduction and spread in CCHF-free countries in southern and Western Europe: A semi-quantitative risk assessment
por: Fanelli, Angela, et al.
Publicado: (2021)

Sensitive and specific detection of Crimean-Congo Hemorrhagic Fever Virus (CCHFV)—Specific IgM and IgG antibodies in human sera using recombinant CCHFV nucleoprotein as antigen in μ-capture and IgG immune complex (IC) ELISA tests
por: Emmerich, Petra, et al.
Publicado: (2018)

Crimean-Congo hemorrhagic fever virus nucleocapsid protein has dual RNA binding modes
por: Jeeva, Subbiah, et al.
Publicado: (2017)

An Attenuated HSV-1-Derived Malaria Vaccine Expressing Liver-Stage Exported Proteins Induces Sterilizing Protection against Infectious Sporozoite Challenge
por: Rider, Paul J. F., et al.
Publicado: (2022)

Comparison of diagnostic performances of ten different immunoassays detecting anti-CCHFV IgM and IgG antibodies from acute to subsided phases of Crimean-Congo hemorrhagic fever
por: Emmerich, Petra, et al.
Publicado: (2021)

Development of a novel recombinant ELISA for the detection of Crimean-Congo hemorrhagic fever virus IgG antibodies
por: Gülce-İz, Sultan, et al.
Publicado: (2021)

Co-Delivery Effect of CD24 on the Immunogenicity and Lethal Challenge Protection of a DNA Vector Expressing Nucleocapsid Protein of Crimean Congo Hemorrhagic Fever Virus
por: Aligholipour Farzani, Touraj, et al.
Publicado: (2019)

Crimean-Congo haemorrhagic fever
por: Ergönül, Önder
Publicado: (2006)

Vaccination with the Crimean-Congo hemorrhagic fever virus viral replicon vaccine induces NP-based T-cell activation and antibodies possessing Fc-mediated effector functions
por: Scholte, F. E. M., et al.
Publicado: (2023)

Immunological Analysis of a CCHFV mRNA Vaccine Candidate in Mouse Models
por: Aligholipour Farzani, Touraj, et al.
Publicado: (2019)

Nucleocapsid protein-based vaccine provides protection in mice against lethal Crimean-Congo hemorrhagic fever virus challenge
por: Zivcec, Marko, et al.
Publicado: (2018)

Multiplex Assay for Simultaneous Detection of Antibodies against Crimean-Congo Hemorrhagic Fever Virus Nucleocapsid Protein and Glycoproteins in Ruminants
por: Hoste, Alexis C. R., et al.
Publicado: (2023)

An Update on Crimean Congo Hemorrhagic Fever
por: Appannanavar, Suma B, et al.
Publicado: (2011)

Crimean-Congo Hemorrhagic Fever in Bulgaria
por: Papa, Anna, et al.
Publicado: (2004)

Crimean-Congo Hemorrhagic Fever in Turkey
por: Karti, S. Sami, et al.
Publicado: (2004)

Crimean-Congo Hemorrhagic Fever, Mauritania
por: Nabeth, Pierre, et al.
Publicado: (2004)

Crimean-Congo hemorrhagic fever in children
por: Tezer, Hasan, et al.
Publicado: (2010)

Crimean-Congo Hemorrhagic Fever, Mauritania
por: Boushab, Boushab Mohamed, et al.
Publicado: (2020)

Treatment of Crimean-Congo Hemorrhagic Fever
por: Ergonul, Onder, et al.
Publicado: (2007)

Crimean–Congo haemorrhagic fever virus
por: Hawman, David W., et al.
Publicado: (2023)

Development of anti-Crimean-Congo hemorrhagic fever virus Gc and NP-specific ELISA for detection of antibodies in domestic animal sera
por: Belij-Rammerstorfer, Sandra, et al.
Publicado: (2022)

Epitope-Based Immunoinformatics and Molecular Docking Studies of Nucleocapsid Protein and Ovarian Tumor Domain of Crimean–Congo Hemorrhagic Fever Virus
por: Srinivasan, Pappu, et al.
Publicado: (2011)

Differential Growth Characteristics of Crimean-Congo Hemorrhagic Fever Virus in Kidney Cells of Human and Bovine Origin
por: Földes, Katalin, et al.
Publicado: (2020)

Mapping of B-cell epitopes on the N- terminal and C-terminal segment of nucleocapsid protein from Crimean-Congo hemorrhagic fever virus
por: Moming, Abulimiti, et al.
Publicado: (2018)

Crimean-Congo Hemorrhagic Fever, Southwestern Bulgaria
por: Christova, Iva, et al.
Publicado: (2009)

Crimean-Congo Hemorrhagic Fever, Afghanistan, 2009
por: Mustafa, Mir Lais, et al.
Publicado: (2011)

Human Crimean-Congo Hemorrhagic Fever, Sénégal
por: Nabeth, Pierre, et al.
Publicado: (2004)

Cannot write session to /tmp/vufind_sessions/sess_j97i0g3t6o4qp6hr4abjpdptj0